Crewe Advisors LLC Sarepta Therapeutics, Inc. Transaction History

Crewe Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$102.5 - $123.59 $102 - $123	1 New	1 $0
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $2,938 - $3,899	-25 Reduced 10.55%	212 $29,000
Q2 2022 Aug 02, 2022	BUY	$62.69 - $88.44 $14,857 - $20,960	237 New	237 $18,000
Q1 2021 Apr 21, 2021	SELL	$72.25 - $168.95 $433 - $1,013	-6 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$125.56 - $178.74 $1,130 - $1,608	-9 Reduced 60.0%	6 $1,000
Q3 2020 Oct 13, 2020	BUY	$127.12 - $172.34 $1,906 - $2,585	15 New	15 $2,000

536

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.82B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.